Cytochrome P450 2A6/7/13 Antikörper
Kurzübersicht für Cytochrome P450 2A6/7/13 Antikörper (ABIN6261195)
Target
Reaktivität
Wirt
Klonalität
Applikation
-
-
Spezifität
- Cytochrome P450 2A6/7/13 Antibody detects endogenous levels of total Cytochrome P450 2A6/7/13
-
Kreuzreaktivität
- Human
-
Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human Cytochrome P450 2A6/7/13
-
Isotyp
- IgG
-
-
-
Applikationshinweise
- WB 1:1000-3000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C.Stable for 12 months from date of receipt
-
Haltbarkeit
- 12 months
-
-
- Cytochrome P450 2A6/7/13
-
Hintergrund
-
Description: Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity.
Gene: CYP2A6
-
Molekulargewicht
- 56 kDa
-
Gen-ID
- 1548
-
UniProt
- P11509, P20853, Q16696
Target
-